Intuitive Surgical Free Cash Flow 2010-2024 | ISRG

Intuitive Surgical free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • Intuitive Surgical annual free cash flow for 2024 was $1.304B, a 73.93% increase from 2023.
  • Intuitive Surgical annual free cash flow for 2023 was $0.75B, a 21.79% decline from 2022.
  • Intuitive Surgical annual free cash flow for 2022 was $0.958B, a 45.23% decline from 2021.

Intuitive Surgical Free Cash Flow 2010-2024 | ISRG

  • Intuitive Surgical annual free cash flow for 2024 was $1.304B, a 73.93% increase from 2023.
  • Intuitive Surgical annual free cash flow for 2023 was $0.75B, a 21.79% decline from 2022.
  • Intuitive Surgical annual free cash flow for 2022 was $0.958B, a 45.23% decline from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$203.4B
Edwards Lifesciences (EW)$44.9B
Alcon (ALC)$44.4B
IDEXX Laboratories (IDXX)$36.4B
DexCom (DXCM)$34.8B
IQVIA Holdings (IQV)$34.1B
Mettler-Toledo (MTD)$26.6B
Waters (WAT)$22B
STERIS (STE)$21.6B
SONOVA HOLDING (SONVY)$20B
Hologic (HOLX)$14.2B
Fresenius Medical Care AG KGaA (FMS)$13.8B
Globus Medical (GMED)$11.4B
Sysmex ADR (SSMXY)$11.3B
Penumbra (PEN)$10.3B
Masimo (MASI)$9.7B
Glaukos (GKOS)$8.4B
Teleflex (TFX)$7.8B
Integer Holdings (ITGR)$4.7B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$3.5B
Veracyte (VCYT)$3.2B
Nihon Kohden (NHNKY)$2.7B
LivaNova (LIVN)$2.6B
TransMedics (TMDX)$2.4B
Elekta AB (EKTAY)$2.4B
Tandem Diabetes Care (TNDM)$2.2B
Integra LifeSciences Holdings (IART)$1.9B
Alphatec Holdings (ATEC)$1.5B
Pulse Biosciences (PLSE)$1.3B